BioWa, Inc.
Corporate Office
212 Carnegie Center, Suite 101
Princeton
New Jersey
08540
United States
Tel: 609-580-7500
Fax: 609-919-1108
Website: http://www.biowa.com/
Email: info@biowa.com
33 articles about BioWa, Inc.
-
Cantargia and BioWa Extend Ongoing Collaboration around the POTELLIGENT® Technology
8/23/2019
Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENT® Technology for production of Cantargia’s antibody drug candidate CAN04, which gives Cantargia broader rights to use the technology.
-
Lonza Inc. and BioWa Sign License Agreements with FivePrime Therapeutics, Inc. for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development
6/13/2012
-
arGEN-X Announces Non-exclusive License with BioWa for Potelligent® Technology
7/26/2011
-
arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
7/25/2011
-
ImmunoCellular Therapeutics, Ltd and BioWa Announce License for the Research and Development of Therapeutic Antibodies in Cancer
6/2/2011
-
Oxford BioTherapeutics Licenses BioWa's POTELLIGENT(R) Technology for the Research and Development of its Therapeutic Antibodies in Cancer
4/6/2011
-
KaloBios Pharmaceuticals, Inc. Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Humaneered(TM) Antibodies
2/8/2011
-
Daiichi Sankyo, Inc. Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Recombinant Antibodies
6/26/2010
-
BioWa Announces Expansion of Licenses to GlaxoSmithKline
6/23/2010
-
BioWa and NKT Therapeutics Inc. Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development
10/21/2009
-
BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA
7/15/2009
-
BioWa Announces License of POTELLIGENT(R) Technology to Sanofi-Aventis (France)
4/8/2009
-
BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
12/8/2008
-
BioWa Announces License of Biowa's Potelligent(R) Technology to KaloBios Pharmaceuticals, Inc.
10/28/2008
-
BioWa Licenses POTELLIGENT(R) Technology to CSL Limited
10/9/2008
-
BioWa and Medarex, Inc. Announce License of BioWa's COMPLEGENT(TM) Technology
7/16/2008
-
BioWa Licenses POTELLIGENT(R) Technology to Major Pharmaceutical Company for Use in Antibody Research and Development
6/11/2008
-
BioWa Announces Expansion of License Agreement with Genentech, Inc.
3/3/2008
-
BioWa Announces Extended Licensing to MedImmune, Inc. of POTELLIGENT(R) Technology for Use in Antibody Research And Development
10/25/2007
-
BioWa Announces Licensing of POTELLIGENT(R) Technology by GlaxoSmithKline
10/19/2007